(Q45877438)

17 December 2017

editorial

0 references

title

Gene therapy for human bypass grafts (English)

1 reference

17 December 2017

0 references

Mangi AA

1

1 reference

17 December 2017

Dzau VJ

series ordinal

2

1 reference

17 December 2017

language of work or name

English

0 references

publication date

1 April 2001

1 reference

17 December 2017

published in

Annals of Medicine

1 reference

17 December 2017

volume

33

1 reference

17 December 2017

issue

3

1 reference

17 December 2017

page(s)

153-155

1 reference

17 December 2017

The future of saphenous vein as a coronary artery bypass conduit

cites work

1 reference

https://api.crossref.org/works/10.3109%2F07853890109002071

Effect of p53 gene therapy combined with CTLA4Ig selective immunosuppression on prolonged neointima formation reduction in a rat model

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890109002071

Adenoviral RB2/p130 gene transfer inhibits smooth muscle cell proliferation and prevents restenosis after angioplasty

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890109002071

Adenovirus-mediated delivery of fas ligand inhibits intimal hyperplasia after balloon injury in immunologically primed animals

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890109002071

Downregulation of cyclin G1 expression by retrovirus-mediated antisense gene transfer inhibits vascular smooth muscle cell proliferation and neointima formation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890109002071

Adenovirus-mediated over-expression of the cyclin/cyclin-dependent kinase inhibitor, p21 inhibits vascular smooth muscle cell proliferation and neointima formation in the rat carotid artery model of balloon angioplasty

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890109002071

Cytostatic gene therapy for vascular proliferative disorders with a constitutively active form of the retinoblastoma gene product

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890109002071

Adenovirus-mediated gene transfer into normal rabbit arteries results in prolonged vascular cell activation, inflammation, and neointimal hyperplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890109002071

A gene therapy strategy using a transcription factor decoy of the E2F binding site inhibits smooth muscle proliferation in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890109002071

Genetic engineering of vein grafts resistant to atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890109002071

Ex-vivo gene therapy of human vascular bypass grafts with E2F decoy: the PREVENT single-centre, randomised, controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853890109002071

10.3109/07853890109002071

21 January 2018

Identifiers

DOI

1 reference

17 December 2017

PubMed ID

11370767

1 reference

17 December 2017